← Leaderboards
Lynn Bekris
University Of Washington
$5,897,031
Attributed
$9,445,888
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,445,888 · 8
By mechanism
U01$3,966,759 · 1
P30$2,556,231 · 3
R56$1,943,776 · 2
R00$724,890 · 1
K99$254,232 · 1
Top collaborators
- Feixiong Cheng6 shared
- James Bruce Leverenz6 shared
- Justin D. Lathia1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Eberhard E Fetz$14,864,842
- Geraldine Dawson$27,808,744
- James Bruce Leverenz$18,891,620
- William Noble$1,403,272
- Ellen M Wijsman$16,921,787
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseNeurodegenerative DisordersGeneticCerebrospinal FluidMolecularDementiaFoundationsS Disease Related DementiaInnovationLinkClinicDatabasesGenesDiagnosisBrainClinical DataBiobankPathogenesisPlasmaTau ProteinsResearch PersonnelAllelesGenotype
Grant awards (19)
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery$780,607
U01 · FY2025 · AG
Biomarker Core$564,910
P30 · FY2025 · AG · contact PI
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery$796,538
U01 · FY2024 · AG
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery$796,538
U01 · FY2023 · AG
Biomarker Core$464,570
P30 · FY2023 · AG · contact PI
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery$796,538
U01 · FY2022 · AG
Biomarker Core$672,832
P30 · FY2022 · AG · contact PI
Multimodal single-cell genomic and epigenomic analyses elucidate Alzheimerâs sexual dimorphism in human immune systems aging$1,205,802
R56 · FY2021 · AG
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery$796,538
U01 · FY2021 · AG
Biomarker Core$353,400
P30 · FY2021 · AG · contact PI
Biomarker Core$291,002
P30 · FY2020 · AG · contact PI
Peripheral TREM2 Epigenetics and the Immune Response in Neurodegenerative Disorders$737,974
R56 · FY2019 · AG · contact PI
Biomarker Core$209,517
P30 · FY2019 · AG · contact PI
Biomarker Expression and Regulatory Haplotypes in Alzheimer's Disease$249,000
R00 · FY2014 · AG · contact PI
Biomarker Expression and Regulatory Haplotypes in Alzheimer's Disease$170,904
R00 · FY2013 · AG · contact PI
Biomarker Expression and Regulatory Haplotypes in Alzheimer's Disease$59,701
R00 · FY2013 · AG · contact PI
Biomarker Expression and Regulatory Haplotypes in Alzheimer's Disease$245,285
R00 · FY2012 · AG · contact PI
Biomarker Expression and Regulatory Haplotypes in Alzheimer's Disease$127,116
K99 · FY2011 · AG · contact PI
Biomarker Expression and Regulatory Haplotypes in Alzheimer's Disease$127,116
K99 · FY2010 · AG · contact PI